Fundz

Convergent Therapeutics Appoints Elizabeth L. Montgomery as Chief People Officer

PRIVATEJan 28, 2026

Position

Chief People Officer

Company

Convergent Therapeutics

Elizabeth L. Montgomery
CambridgeBiotechnologyHealth CareTherapeutics

Description

Convergent Therapeutics Inc. announces the appointment of Elizabeth L. Montgomery as its Chief People Officer

Quick answer

Convergent Therapeutics Appoints Elizabeth L. Montgomery as Chief People Officer (January 28, 2026). Convergent Therapeutics is based in Cambridge, Massachusetts, United States.

Who is the new Chief People Officer at Convergent Therapeutics?
Convergent Therapeutics named Elizabeth L. Montgomery Chief People Officer, announced January 28, 2026.
What did Convergent Therapeutics announce on January 28, 2026?
Convergent Therapeutics Inc. announces the appointment of Elizabeth L. Montgomery as its Chief People Officer
What does Convergent Therapeutics do?
Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to treat cancer.
Where is Convergent Therapeutics based?
Convergent Therapeutics is based in Cambridge, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Elevar Therapeutics and Relay Therapeutics (January 29, 2026), Lexeo Therapeutics (January 27, 2026), REVEAL GENOMICS (January 27, 2026) and Merz Therapeutics (January 30, 2026) also announced leadership changes within 45 days of Convergent Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Convergent Therapeutics, and when

A new leader at Convergent Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Convergent Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Convergent Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Convergent Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Convergent Therapeutics

Location

Cambridge, Massachusetts, United States

About

Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to treat cancer. Convergent has developed a therapeutic platform that is capable of targeting validated and novel cancer antigens. Building on breakthrough research developed by Dr. Neil Bander at Weill Cornell Medicine, Convergent has demonstrated that dual targeting of surface cancer molecules like Prostate-Specific Membrane Antigen (PSMA) improves antitumor efficacy. By leveraging targeting agents with different bio-distributions, such as monoclonal antibodies and ligands, supra-additive therapeutic doses are delivered to tumor cells without additive toxicity to the patient.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Convergent Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Philip
Likely contact at this company
••••••••@••••••••

See Philip's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Convergent Therapeutics's next move

Learn about Strategic plan

Convergent Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.